CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
British Journal of Cancer 117, 947 (26 September 2017). doi:10.1038/bjc.2017.276
Authors: Maeva Dufies, Sandy Giuliano, Julien Viotti, Delphine Borchiellini, Linsay S Cooley, Damien Ambrosetti, Mélanie Guyot, Papa Diogop Ndiaye, Julien Parola, Audrey Claren, Renaud Schiappa, Jocelyn Gal, Antoine Frangeul, Arnaud Jacquel, Ophélie Cassuto, Renaud Grépin, Patrick Auberger, Andréas Bikfalvi, Gérard Milano, Bernard Escudier, Nathalie Rioux-Leclercq, Camillo Porta, Sylvie Negrier, Emmanuel Chamorey, Jean-Marc Ferrero & Gilles Pagès
from Cancer via ola Kala on Inoreader http://ift.tt/2iHkdNM
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου